|
|
Article: DFine Announces the Appointment of Mr. Kevin Mosher To the Position of CEO.
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DFine Inc., the World's leading developer of Radio Frequency Kyphoplasty products, minimally invasive solutions for treating vertebral compression fractures (VCFs), announced the appointment of Mr. Kevin Mosher, as Chief Executive Officer, effective November 16, 2009 (see also DFine Inc.).
Mr. Mosher comes to DFine from Nobel Biocare, where he served as President of their North American division. During his tenure at Nobel Biocare, Mosher helped grow and build an organization known for its stellar sales execution and consistent profitability. He was a member of the Executive Committee since joining in 2004, and helped guide the organization through several ...
Related newspaper, magazine, and journal articles:
|